A prominent research firm, Cognizance Market Research added a cutting-edge industry report on “Global Single-use Bioprocessing Systems Market”. The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2022 to 2030.
Global Single-use Bioprocessing Systems Market Analysis:
According to cognizance market research, Global Single-use Bioprocessing Systems Market was valued at US$ 9,875.6 million in 2022 and is anticipated to reach US$ 35,165.8 million by the end of 2030 expected to register a CAGR of 17.2% from 2023 to 2030.
What is Single-use Bioprocessing Systems Market?
The market for disposable, single-use components pertains to their use in biomanufacturing processes. These components, such as bags, filters, bioreactors, mixers, and tubing, are designed to reduce contamination risks, enhance product quality, and improve bioprocessing efficiency and flexibility. They are made of biocompatible materials like polyethylene, polypropylene, and silicone, which can withstand the rigorous conditions of biomanufacturing processes.
The global single-use bioprocessing systems market is growing rapidly. This is due to the rising demand for biologics, increased R&D spending, and the increasing acceptance of single-use technologies in biopharmaceutical manufacturing. The COVID-19 pandemic has also highlighted the importance of single-use bioprocessing systems in facilitating quick and flexible biomanufacturing procedures for vaccines and treatments.
Leading participants in the single-use bioprocessing systems market include Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, Danaher Corporation, and GE Healthcare. These companies are investing in R&D to develop new and cost-effective single-use bioprocessing systems. They are also using strategies such as partnerships, product launches, geographic expansions, and mergers and acquisitions to gain and maintain a competitive edge.
Biopharmaceutical firms are rapidly adopting single-use bioprocessing systems due to their significant advantages over traditional stainless steel-based systems. These advantages include lower capital expenditures, better manufacturing flexibility, lower contamination risk, and shorter turnaround times. Additionally, using single-use solutions reduces the need for cleaning, sterilization, and validation, resulting in significant time, labour, and resource savings.
Overall, the single-use bioprocessing systems market is expected to expand significantly in the coming years. This growth will be driven by rising demand for biologics, technical advancements in biomanufacturing, and the increasing use of single-use technologies by biopharmaceutical firms.
Global Single-use Bioprocessing Systems Market Outlook:
The demand for single-use bioprocessing systems is expected to increase in the coming years due to various factors. The rise in demand for biologics, which are complex chemicals made from live cells, is a significant driver of the market. Biopharmaceutical producers are also turning to single-use technology due to benefits like lower capital costs, better manufacturing flexibility, and lower contamination risk. The COVID-19 pandemic has further highlighted the need for quick and flexible biomanufacturing procedures for vaccines and treatments, which has resulted in a surge in demand for single-use bioprocessing systems. This trend is expected to continue beyond the pandemic.
In addition, the market is witnessing the emergence of novel and cost-effective single-use solutions to meet the changing demands of biopharmaceutical producers. However, concerns about the high cost of single-use systems and the disposal of single-use components may limit market growth to some extent. Nevertheless, increased investments in R&D and the development of innovative technologies are expected to create new market opportunities in the future.
The market for single-use bioprocessing systems can be categorized by product type, application, end-user, and geography. The product type category includes bioreactors, mixers, bags, filtration devices, tubing, connectors and clamps, and other items. Bioreactors are commonly used in biopharmaceutical manufacturing to create recombinant proteins, monoclonal antibodies, and vaccines. Mixers are used to mix and blend fluids, while bags are used for fluid storage and transport. Filtration devices are used to remove contaminants and clarify the result. Tubing is used to transport fluids, and connectors and clamps are used to connect and disengage different components. Other items available on the market include sensors, probes, and data management systems for monitoring and regulating bioprocesses.
The application category includes monoclonal antibody manufacturing, vaccine production, plant cell culture, patient-specific cell treatments, and others. Monoclonal antibody manufacturing is predicted to be the dominant segment in the application category due to the rising need for monoclonal antibodies in the treatment of various illnesses such as cancer, autoimmune disorders, and infectious diseases.
The end-user category includes biopharmaceutical manufacturers, contract research and manufacturing organizations (CROs and CMOs), academic and research institutes, and others. Biopharmaceutical manufacturers are likely to be the dominant segment in the end-user category due to the increasing demand for biopharmaceutical products and the expanding usage of single-use technologies in biopharmaceutical manufacturing. The vaccine manufacturing category is predicted to be the fastest-growing segment in the market due to increased demand for vaccines globally and the growing usage of single-use bioprocessing systems in vaccine production.
Based on geography the Global Single-use Bioprocessing Systems Market has been segmented into five main regions namely, North America, Asia Pacific, Europe, Latin America, and Middle East & Africa.
The single-use bioprocessing systems market in North America is the largest and most promising, thanks to the favourable government laws and financing for R&D efforts, as well as the presence of several biopharmaceutical businesses in the region. The United States is the dominant player in the market, accounting for the vast majority of market share. The region’s biopharmaceutical producers’ increased usage of single-use bioprocessing systems and the rising demand for biopharmaceutical products will likely fuel the market’s expansion in North America.
Europe, on the other hand, boasts the second-largest market for single-use bioprocessing systems, owing to the high number of biopharmaceutical businesses in the region and increased R&D spending. The United Kingdom, Germany, and France are the region’s key markets, with favourable government regulations supporting the biopharmaceutical industry’s expansion and rising demand for biopharmaceutical products.
Lastly, the Asia Pacific region is poised for the fastest growth in the single-use bioprocessing systems market, driven by increased R&D spending in countries such as China, India, and Japan, as well as rising demand for biopharmaceutical products. The region’s biopharmaceutical producers’ increased usage of single-use bioprocessing equipment is also expected to contribute to the market’s expansion in the Asia Pacific region.
The report offers the revenue of the Global Single-use Bioprocessing Systems Market for the period 2020-2030, considering 2020 & 2021 as a historical year, 2022 as the base year and 2023 to 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the Single-use Bioprocessing Systems Market for the forecast period. The Global Single-use Bioprocessing Systems Market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the Global Single-use Bioprocessing Systems Market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the Global Single-use Bioprocessing Systems Market.
The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the Global Single-use Bioprocessing Systems Market. Secondary research involved a detailed analysis of significant players’ product portfolios. Literature reviews, press releases, annual reports, white papers, and relevant documents have been also studied to understand the Global Single-use Bioprocessing Systems Market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.
The report includes an executive summary, along with a growth pattern of different segments included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the Global Single-use Bioprocessing Systems Market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the Global Single-use Bioprocessing Systems Market. The subsequent section of the Global Single-use Bioprocessing Systems Market report highlights the USPs, which include key industry events (Type launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenario.
Global Single-use Bioprocessing Systems Market Competitive Landscape:
Here are some of the top participants in the global single-use bioprocessing systems industry, as well as their most recent developments:
In September 2021, Thermo Fisher Scientific Inc. will introduce a new single-use mixing solution designed to enable effective mixing and blending of liquid solutions in bioprocessing applications.
Merck KGaA and CSL Behring formed cooperation in July 2021 with the goal of increasing the availability of biologic treatments for patients globally.
Sartorius AG purchased Xell AG, a prominent developer and manufacturer of microcarrier technology for cell culture applications, in April 2021 to extend its product range in the market for single-use bioprocessing systems.
Danaher Corporation acquired Aldevron, a prominent source of high-quality plasmid DNA, proteins, and antibodies used in biopharmaceutical research and development, in March 2021.
Global Single-use Bioprocessing Systems Market, By Product Type:
Global Single-use Bioprocessing Systems Market, By Application:
Global Single-use Bioprocessing Systems Market, By End-User:
Global Single-use Bioprocessing Systems Market, by region:
The rising need for biopharmaceuticals, developments in single-use technology, and the advantages given by single-use systems over traditional stainless-steel systems are the primary drivers driving market expansion.
Concerns about the quality and safety of single-use components, the restricted scalability of certain single-use systems, and the lack of industry standardisation are among the market’s significant obstacles.
The market’s major segments and subsegments include, among others, the bioreactors segment, the filtration and separation sector, and the mixing systems section.
The Asia-Pacific region is predicted to see the largest market growth, owing to factors such as rising demand for biopharmaceuticals, a thriving biotech industry, and favourable government initiatives.
It is projected to reach US$ 35,165.8 million by the end of 2030
Get insights that lead to new growth opportunities
We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail